Clinical Trial Update: Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a combination of chemotherapy, a monoclonal antibody, and radiation therapy for primary central nervous system lymphoma ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Central Nervous System Lymphoma

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-07